Showing articles with keyword: Notre Dame | CLEAR

January 18, 2017

Applications Sought for Design and Biostatistics Program Pilot Grant

Design and Biostatistics Program (DBP) Pilot Grant – 2017.02
LETTER OF INTENT (LOI) DEADLINE – DECEMBER 16, 2016
FULL APPLICATION DEADLINE – FEBRUARY 6, 2017 (5:00 PM)

The Design and Biostatistics Program (DBP) of the Indiana Clinical and Translational Science Institute (CTSI) is comprised of 8 units with associated expertise:  1) Department of Biostatistics, IU School of Medicine and Fairbanks School of Public Health; 2) Division of Hereditary Genomics, Department of Medical & Molecular Genetics, IU School of Medicine; 3) Computational Biology, Center for Computational Biology & Bioinformatics, IU School of Medicine; 4) Department of Epidemiology, Fairbanks School of Public Health; 5)...

January 10, 2017

Applications Sought for IIMR VA Young Investigator Award

LETTER OF INTENT (LOI) DEADLINE- JANUARY 18, 2017
APPLICATION SUBMISSION DEADLINE – FEBRUARY 08, 2017
Description
IIMR’s mission is to promote and enhance research efforts that will ultimately result in improved quality of life for veterans and for the greater population. In support of that mission, IIMR works to encourage investigators to develop their research careers by working with IIMR and the VA and veterans to answer important questions. One way IIMR encourages investigators is to sponsor the annual Young Investigator Award Program, which provides a competitive experience for investigators to explore the possibilities of VA-related research.
The IIMR is currently seeking submissions...

November 1, 2016

Carmel Egan Joins Indiana CTSI

Carmel Egan, PhD
Carmel Egan, PhD, a top project management and product development executive at Eli Lilly and Co., has joined the Indiana University School of Medicine as project leader of IU’s Precision Health Initiative.
Dr. Egan, vice president, Medicines Development Unit at Lilly, has held a series of leadership positions at Lilly. Prior to her most recent position at Lilly, she served as Vice President of special Alzheimer’s disease initiatives in Lilly’s Biomedicines Business Unit and previously as Vice President of LRL Portfolio and Project Management.
She will coordinate activities of the Precision Health Initiative as part of her role as...